摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(7-Bromo-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)acetic acid | 187479-30-7

中文名称
——
中文别名
——
英文名称
2-(7-Bromo-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)acetic acid
英文别名
——
2-(7-Bromo-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)acetic acid化学式
CAS
187479-30-7
化学式
C10H7BrN2O4
mdl
——
分子量
299.081
InChiKey
PHJMZTSMPHBRFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    95.5
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(7-Bromo-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)acetic acid 在 palladium on activated charcoal 氢气三乙胺 作用下, 以 甲醇 为溶剂, 生成 2-(2,3-Dioxo-1,4-dihydroquinoxalin-5-yl)acetic acid
    参考文献:
    名称:
    5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition
    摘要:
    NMDA antagonists derived from 5-phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione (3a) are potent anticonvulsant agents, and display strong protective effects in the electroshock-induced convulsion assay in mice. Their preference for the human NMDAR 1A/2A over 1A/2B subunit composition was optimized, leading to (1RS, 1'S)-PEAQX (9r), which shows a > 100-fold selectivity. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00074-4
  • 作为产物:
    参考文献:
    名称:
    5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition
    摘要:
    NMDA antagonists derived from 5-phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione (3a) are potent anticonvulsant agents, and display strong protective effects in the electroshock-induced convulsion assay in mice. Their preference for the human NMDAR 1A/2A over 1A/2B subunit composition was optimized, leading to (1RS, 1'S)-PEAQX (9r), which shows a > 100-fold selectivity. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00074-4
点击查看最新优质反应信息

文献信息

  • 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition
    作者:Yves P Auberson、Hans Allgeier、Serge Bischoff、Kurt Lingenhoehl、Robert Moretti、Markus Schmutz
    DOI:10.1016/s0960-894x(02)00074-4
    日期:2002.4
    NMDA antagonists derived from 5-phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione (3a) are potent anticonvulsant agents, and display strong protective effects in the electroshock-induced convulsion assay in mice. Their preference for the human NMDAR 1A/2A over 1A/2B subunit composition was optimized, leading to (1RS, 1'S)-PEAQX (9r), which shows a > 100-fold selectivity. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多